SBIR/STTR Research Award
REPLICA CLONING OF THE IMMUNOGLOBULIN RESPONSE
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1992Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- STRATAGENE
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
WE HAVE OUTLINED THE DEVELOPMENT OF MOLECULAR BIOLOGY TECHNIQUES TO CLONE MONOCLONAL ANTIBODIES(MABS). MURINE MABS ARE BEING USED MANY CLINICAL APPLICATIONS SUCH AS CANCER, SEPTIC SHOCK ANDTRANSPLANTATION. THE USE OF HUMAN MABS WOULD OBVIATE THE HUMAN ANTI-MOUSE MAB RESPONSE WHICH OFTEN BLUNTS THE CLINICAL USEFULNESS OF MAB IMMUNOTHERAPY. HOWEVER, FOR MOST INDICATIONS HUMANMABS ARE VERY DIFFICULT OR IMPOSSIBLE TO OBTAIN. HUMAN MABS MADE BY THE PROPOSED METHOD MAY NOT HAVE THE SAME RESTRICTIONS AS CONVENTIONALLY PRODUCED MABS, AND THUS COULD BE OF GREAT PRACTICAL UTILITY. THE RECOMBINANT DNA CLONING TECHNIQUES THAT WE HAVE DESIGNED WILL ALLOW US TO REPLICATE A HUMAN ANTIBODY RESPONSE TO EITHER A FOREIGN ANTIGEN, SUCH AS AIDS VIRUS COAT PROTEIN, OR SELF ANTIGENS, SUCH AS TUMOR MARKERS. A SUCCESSFUL REPLICA CLONING STRATEGY WILL GREATLY FACILITATE THE IDENTIFICATION OF CLINICALLY USEFUL HUMAN MONOCLONAL ANTIBODIES.
Technology keywords
Not reported